Search For "sars"
New study looks at post-COVID-19 emerging disease in children
Updated : 5 years, 8 months ago IST
Illinois [USA], June 26 (ANI): In recent weeks, a multisystem hyperinflammatory condition has emerged in children in association with prior exposure or infection to SARS-CoV-2.
Read More
Study reveals babies with COVID-19 tend to have mild illness, mostly with
Updated : 5 years, 8 months ago IST
Chicago (Illinois) [USA], June 20 (ANI): Infants under 90 days of age who tested positive for COVID-19 tend to be well, with little or no respiratory involvement and fever is often found to be the primary or only symptom, says a new study.
Read More
Tevero becomes the first brand to launch masks in India finished with text
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 17 (ANI/PRNewswire): The Coronavirus Pandemic is a problem that is unfortunately here to stay. A virus, spread so far and wide is going to be challenging to eradicate.
Read More
Boat artisans suffer hardship in Kanpur amid COVID-19
Updated : 5 years, 9 months ago IST
Kanpur (Uttar Pradesh) [India], June 17 (ANI): Boat artisans in Sarsaiya Ghat of Kanpur face hardship as the customers are not turning up to buy boats during the COVID-19 pandemic.
Read More
Cancer immunotherapy tools help researchers identify targets for COVID-19
Updated : 5 years, 9 months ago IST
Philadelphia [USA], June 13 (ANI): In a breakthrough study, a team of cancer researchers have implied a strategy using the tools used for the development of cancer immunotherapies and adapted them to identify the 'right protein sequences to target in SARS-CoV-2,' the virus that causes cor
Read More
Tevero becomes the first brand to launch masks in India finished with text
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 12 (ANI/PRNewswire): The coronavirus pandemic is a problem that is unfortunately here to stay. A virus, spread so far and wide is going to be challenging to eradicate.
Read More
Researchers analyse genomic determinants of coronavirus pathogenicity
Updated : 5 years, 9 months ago IST
Washington DC [USA], June 11 (ANI): A recent analysis led by a team of researchers found crucial genomic features that are unique to SARS-CoV-2, the virus that causes COVID-19, and two other deadly coronaviruses, SARS-CoV and MERS-CoV.
Read More
PerkinElmer receives commercial approval from the Central Drugs Standard C
Updated : 5 years, 9 months ago IST
New Delhi [India] June 10 (ANI/BusinessWire India): PerkinElmer, Inc, a global leader committed to innovating for a healthier world, today announced that PerkinElmer India has received commercial approval by the Central Drugs Standard Control Organization (CDSCO) for the PerkinElmer new coro
Read More
Over 5 million COVID-19 tests done: ICMR
Updated : 5 years, 9 months ago IST
New Delhi [India], June 10 (ANI): Over five million RT-PCR tests to detect SARS-CoV-2 -- the virus behind COVID-19 pandemic - have been done in the country, India Council of Medical Research (ICMR) has said.
Read More
China's inactivated COVID-19 vaccine shows potent protection against SARS-
Updated : 5 years, 9 months ago IST
Beijing [China], June 9 (ANI): China's inactivated COVID-19 vaccine has shown protection against coronavirus infection in animal experiments, Xinhua reported citing a study published in the journal Cell.
Read More
Researchers identify targets for COVID-19 vaccine using cancer immunothera
Updated : 5 years, 9 months ago IST
Philadelphia [USA], June 9 (ANI): A team of cancer researchers have applied the strategy of using the tools used for the development of cancer immunotherapies and adapted them to identify the 'right protein sequences to target in SARS-CoV-2,' the virus that causes coronavirus.
Read More
A2A Pharmaceuticals collaborates with LAXAI Life Sciences to Co-develop SA
Updated : 5 years, 9 months ago IST
Hyderabad (Telangana) [India], June 9 (ANI/PRNewswire): A2A Pharmaceuticals, a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents announces today an agreement to co-develop SARS-CoV-2 Main Proteases inhibitors for the treatment of
Read More